Efficacy and safety of prolonged‐release tacrolimus in stable pediatric allograft recipients converted from immediate‐release tacrolimus – a Phase 2, open‐label, single‐arm, one‐way crossover study-Reference-Cited by-同舟云学术

Efficacy and safety of prolonged‐release tacrolimus in stable pediatric allograft recipients converted from immediate‐release tacrolimus – a Phase 2, open‐label, single‐arm, one‐way crossover study

Published:2019-08-27 Issue:11 Volume:32 Page:1182-1193
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

Rubik Jacek¹,Debray Dominique²^ORCID,Kelly Deirdre³,Iserin Franck⁴,Webb Nicholas J. A.⁵,Czubkowski Piotr⁶,Vondrak Karel⁷,Sellier‐Leclerc Anne‐Laure⁸,Rivet Christine⁹,Riva Silvia¹⁰,Tönshoff Burkhard¹¹,D'Antiga Lorenzo¹²^ORCID,Marks Stephen D.¹³^ORCID,Reding Raymond¹⁴,Kazeem Gbenga¹⁵¹⁶,Undre Nasrullah¹⁶^ORCID

Affiliation:

1. Department of Nephrology, Kidney Transplantation and Hypertension The Children's Memorial Health Institute Warsaw Poland

2. Pediatric Hepatology Unit APHP‐Hôpital Universitaire Necker Paris France

3. The Liver Unit Birmingham Women's & Children's Hospital Birmingham UK

4. Pediatric Cardiology Unit APHP‐Hôpital Universitaire Necker Paris France

5. Department of Pediatric Nephrology NIHR/Wellcome Trust Manchester Clinical Research Facility Manchester Academic Health Science Centre Royal Manchester Children's Hospital University of Manchester Manchester UK

6. Department of Gastroenterology, Hepatology, Nutritional Disturbances and Pediatrics The Children's Memorial Health Institute Warsaw Poland

7. Department of Pediatrics Second School of Medicine University Hospital Motol Charles University Prague Czech Republic

8. Department of Nephrology, Rheumatology, and Dermatology Center for Rare Diseases Civil Hospice of Lyon ‘Woman‐Mother‐Child’ Hospital Bron Cedex France

9. Pediatric Hepatology, Gastroenterology and Transplantation Civil Hospice of Lyon Lyon France

10. Department of Pediatrics ISMETT–IRCCS Palermo Italy

11. Department of Pediatrics I University Children's Hospital Heidelberg Heidelberg Germany

12. Pediatric Hepatology, Gastroenterology and Transplantation Hospital Papa Giovanni XXIII Bergamo Italy

13. Department of Pediatric Nephrology Great Ormond Street Hospital for Children NHS Foundation Trust London UK

14. Unité de Chirurgie et Transplantation Pédiatrique Cliniques Universitaires Saint-Luc Université Catholique de Louvain Brussels Belgium

15. BENKAZ Consulting Ltd Cambridge UK

16. Astellas Pharma Europe Ltd Chertsey UK

Funder

Astellas Pharma Europe

National Institute on Handicapped Research

Publisher

Frontiers Media SA

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tri.13479

Reference36 articles.

1. OPTN/SRTR 2016 Annual Data Report: Liver

2. OPTN/SRTR 2016 Annual Data Report: Kidney

3. Astellas Pharma Europe Ltd.Prograf 0.5 mg 1 mg 5 mg hard capsules summary of product characteristics.https://www.medicines.org.uk/emc/product/6720. Accessed April 17 2019.

4. US Food and Drug Administration.Astagraf XL prescribing information.https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204096s005lbl.pdf. Accessed February 14 2019.

5. Astellas Pharma Europe Ltd.Advagraf 0.5 mg 1 mg 3 mg and 5 mg prolonged‐release hard capsules summary of product characteristics.https://www.medicines.org.uk/emc/product/345/smpc. Accessed February 20 2019.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of once‐daily LCP‐Tacrolimus with adolescent and young adult solid organ transplant recipients;Pediatric Transplantation;2024-05-03

2. A multi-center interventional study to assess pharmacokinetics, effectiveness, and tolerability of prolonged-release tacrolimus after pediatric kidney transplantation: study protocol for a prospective, open-label, randomized, two-phase, two-sequence, single dose, crossover, phase III b trial;Frontiers in Nephrology;2024-02-20

3. The effect of tacrolimus conversion from immediate- to extended-release formulation on renal function in renal transplant patients: a meta-analysis;Frontiers in Pharmacology;2023-10-04

4. The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients;The Journal of Heart and Lung Transplantation;2023-05

5. Immunosuppression in Pediatric Kidney Transplantation;Pediatric Kidney Disease;2023